C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

⚠ Non-Billable ICD-10-CM 2026
Open C39 in Web App →

The ICD-10-CM code for Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs is C39 (FY2026). It is a non-billable category code — select a more specific code below for claims.

Classification

Section
C30-C39: Malignant neoplasms of respiratory and intrathoracic organs (C30-C39)
Category C39
3 codes (2 billable)
FY2026 Status
Stable since FY2024
Excludes1
Not coded here. These conditions should NOT be coded together with C39.
  • intrathoracic malignant neoplasm NOS (C76.1)
  • thoracic malignant neoplasm NOS (C76.1)
Use Additional Code
  • code to identify:
  • exposure to environmental tobacco smoke (Z77.22)
  • exposure to tobacco smoke in the perinatal period (P96.81)
  • history of tobacco dependence (Z87.891)
  • occupational exposure to environmental tobacco smoke (Z57.31)
  • tobacco dependence (F17.-)
  • tobacco use (Z72.0)

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial